110 related articles for article (PubMed ID: 11952509)
1. Comparison of two filter combinations for low-density lipoprotein apheresis by membrane differential filtration: a prospective crossover controlled clinical study.
Matic G; Kohlschein P; Wallstab U; Tiess M; Winkler R; Prophet H; Ramlow W; Schuff-Werner P
Artif Organs; 2002 Apr; 26(4):371-7. PubMed ID: 11952509
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of double filtration plasmapheresis, thermofiltration, and low-density lipoprotein adsorptive methods by crossover test in the treatment of familial hypercholesterolemia patients.
Suzuki M; Yamane S; Matsugane T; Nobuto T; Azuma N; Nishide T; Shinomiya M; Saito K; Sasaki N; Nosé Y
Artif Organs; 1996 Apr; 20(4):296-302. PubMed ID: 8860710
[TBL] [Abstract][Full Text] [Related]
3. Clinical hemocompatibility of double-filtration lipoprotein apheresis comparing polyethersulfone and ethylene-vinyl alcohol copolymer membranes.
Krieter DH; Jeyaseelan J; Rüth M; Lemke HD; Wanner C; Drechsler C
Artif Organs; 2021 Sep; 45(9):1104-1113. PubMed ID: 33617653
[TBL] [Abstract][Full Text] [Related]
4. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
[TBL] [Abstract][Full Text] [Related]
5. An effective LDL removal filter for the treatment of hyperlipidemia.
Matsuda Y; Sueoka A; Nosé Y
Artif Organs; 1995 Feb; 19(2):129-34. PubMed ID: 7763191
[TBL] [Abstract][Full Text] [Related]
6. Three different schedules of low-density lipoprotein apheresis compared with plasmapheresis in patients with homozygous familial hypercholesterolemia.
Berger GM; Firth JC; Jacobs P; Wood L; Marais AD; Horak A
Am J Med; 1990 Feb; 88(2):94-100. PubMed ID: 2105647
[TBL] [Abstract][Full Text] [Related]
7. Membranes for therapeutic apheresis.
Nakaji S; Yamamoto T
Ther Apher; 2002 Aug; 6(4):267-70. PubMed ID: 12164795
[TBL] [Abstract][Full Text] [Related]
8. Removal and recovery of cholesterol in thermofiltration.
Takeyama Y; Malchesky PS; Cressman MD; Yamashita M; Horiuchi T; Usami M; Koo AP; Pence G; Nose Y
Int J Artif Organs; 1988 May; 11(3):201-8. PubMed ID: 3403058
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Fractionation Membranes in an Animal Model of Double Filtration Lipoprotein Apheresis.
Krieter DH; Lange F; Lemke HD; Bonn F; Wanner C
Ther Apher Dial; 2018 Apr; 22(2):189-195. PubMed ID: 29316258
[TBL] [Abstract][Full Text] [Related]
10. Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS).
Tsuchida H; Shigematsu H; Ishimaru S; Iwai T; Akaba N; Umezu S
Int Angiol; 2006 Sep; 25(3):287-92. PubMed ID: 16878078
[TBL] [Abstract][Full Text] [Related]
11. Low density lipoprotein apheresis in pediatric patients with homozygous familial hypercholesterolemia.
Coker M; Ucar SK; Simsek DG; Darcan S; Bak M; Can S
Ther Apher Dial; 2009 Apr; 13(2):121-8. PubMed ID: 19379151
[TBL] [Abstract][Full Text] [Related]
12. Prospective crossover study for a standardized comparison of the dextrane sulfate whole blood and plasma apheresis system in patients with cardiovascular disease and severe dyslipidemia.
Ramlow W; Prophet H; Waitz G
Atheroscler Suppl; 2017 Nov; 30():99-107. PubMed ID: 29096869
[TBL] [Abstract][Full Text] [Related]
13. Low-density lipoprotein removal methods by membranes and future perspectives.
Matsuda Y; Malchesky PS; Nosé Y
Artif Organs; 1996 Apr; 20(4):346-54. PubMed ID: 9139623
[TBL] [Abstract][Full Text] [Related]
14. Association of lipoprotein(a) level with short- and long-term outcomes after CABG: The role of lipoprotein apheresis.
Ezhov MV; Afanasieva OI; Il'ina LN; Safarova MS; Adamova IY; Matchin YG; Konovalov GA; Akchurin RS; Pokrovsky SN
Atheroscler Suppl; 2017 Nov; 30():187-192. PubMed ID: 29096836
[TBL] [Abstract][Full Text] [Related]
15. A high selectivity cascade filtration technique for LDL-cholesterol and Lp(a) removal.
Legallais C; Morinière P; Wojcicki JM; Lalau JD; Fournier A; Jaffrin MY
Artif Organs; 1995 Sep; 19(9):887-95. PubMed ID: 8687294
[TBL] [Abstract][Full Text] [Related]
16. Defining the role of lipoprotein apheresis in the management of familial hypercholesterolemia.
Lee WP; Datta BN; Ong BB; Rees A; Halcox J
Am J Cardiovasc Drugs; 2011 Dec; 11(6):363-70. PubMed ID: 22149315
[TBL] [Abstract][Full Text] [Related]
17. Apheretic treatment of severe familial hypercholesterolemia: comparison of dextran sulfate cellulose and double membrane filtration methods for low density lipoprotein removal.
Franceschini G; Busnach G; Vaccarino V; Calabresi L; Gianfranceschi G; Sirtori CR
Atherosclerosis; 1988 Oct; 73(2-3):197-202. PubMed ID: 2461207
[TBL] [Abstract][Full Text] [Related]
18. Asparaginase-associated concurrence of hyperlipidemia, hyperglobulinemia, and thrombocytosis was successfully treated by centrifuge/membrane hybrid double-filtration plasmapheresis.
Wang T; Xu B; Fan R; Liu Z; Gong D
J Clin Lipidol; 2016; 10(3):646-9. PubMed ID: 27206953
[TBL] [Abstract][Full Text] [Related]
19. Low-density lipoprotein apheresis decreases ferritin, transferrin and vitamin B12, which may cause anemia in serially treated patients.
Bramlage CP; Armstrong VW; Zapf A; Bramlage P; Mueller GA; Koziolek MJ
Ther Apher Dial; 2010 Apr; 14(2):136-42. PubMed ID: 20438534
[TBL] [Abstract][Full Text] [Related]
20. Membrane versus centrifuge-based therapeutic plasma exchange: a randomized prospective crossover study.
Hafer C; Golla P; Gericke M; Eden G; Beutel G; Schmidt JJ; Schmidt BM; De Reys S; Kielstein JT
Int Urol Nephrol; 2016 Jan; 48(1):133-8. PubMed ID: 26531062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
